Long non-coding RNAs in colorectal cancer

Xia Xie; Bo Tang; Yu-Feng Xiao; Rui Xie; Bo-Sheng Li; Hui Dong; Jian-Yun Zhou; Shi-Ming Yang

doi:10.18632/oncotarget.6446

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Long non-coding RNAs in colorectal cancer

Xia Xie, Bo Tang, Yu-Feng Xiao, Rui Xie, Bo-Sheng Li, Hui Dong, Jian-Yun Zhou and Shi-Ming Yang _

PDF | HTML | How to cite

Oncotarget. 2016; 7:5226-5239. https://doi.org/10.18632/oncotarget.6446

Metrics: PDF 3420 views | HTML 3433 views | ?

Abstract

Xia Xie1, Bo Tang1, Yu-Feng Xiao1, Rui Xie1, Bo-Sheng Li1, Hui Dong1,2, Jian-Yun Zhou1 and Shi-Ming Yang1

1 Department of Gastroenterology, Xinqiao Hospital, Third Military Medical University, Chongqing, P.R. China

2 Division of Gastroenterology, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, California, USA

Correspondence to:

Shi-Ming Yang, email:

Jian-Yun Zhou, email:

Keywords: colorectal cancer, long non-coding RNAs, epigenetic modifications, pseudogenes, X-inactive-specific transcript

Received: August 15, 2015 Accepted: November 21, 2015 Published: December 02, 2015

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Despite substantial progress in understanding the molecular mechanisms and treatment of CRC in recent years, the overall survival rate of CRC patients has not improved dramatically. The development of CRC is multifactor and multistep processes, in which abnormal gene expression may play an important role. With the advance of human tumor molecular biology, a series of studies have highlighted the role of long non-coding RNAs (lncRNAs) in the development of CRC. CRC-related lncRNAs have been demonstrated to regulate the genes by various mechanisms, including epigenetic modifications, lncRNA-miRNA and lncRNA-protein interactions, and by their actions as miRNA precursors or pseudogenes. Since some lncRNAs can be detected in human body fluid and have good specificity and accessibility, they have been suggested to be used as novel potential biomarkers for CRC diagnosis and prognosis as well as in the prediction of the response to therapy. Therefore, in this review, we will focus on lncRNAs in CRC development, the mechanisms and biomarkers of lncRNAs in CRC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6446

Publication Alerts

Reviews:

Long non-coding RNAs in colorectal cancer

Abstract